Atlas Trials

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

Clinical trial NCT00720590 · COMPLETED

Trial details

NCT number
NCT00720590
Sponsor
Indiana University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Endothelial Dysfunction
Start date
2003-11-01
Primary completion
2006-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.